Gilead Sciences news & latest pictures from techtimes.com

Home

Gilead Sciences

COVID-19 Cure Update: US FDA OKs Injected Drug Remdesivir to be Given to Patients

COVID-19 Cure Update: U.S. FDA OKs Issuing Emergency Authorization to Use Injected Drug Remdesivir as Cure to Patients with Coronavirus

The United States Food and Drug Administration (FDA) has finally said yes to one of the potential Coronavirus cure in the country, an injected drug called Remdesivir. Will it be the official COVID-19 cure we're looking for?

by Jamie P.

Health
[BREAKING] COVID-19 Cure: Gilead Shares Remdesivir's Success in 'Crucial Study'
by Nhx Tingson
Health
Pharma Giant Gilead Allegedly Tries to Monopolize the Coronavirus Cure; Retracts the Orphan Drug Status
by Urian B.
Health
Gilead To Donate HIV Prevention Pill Truvada To 200,000 People
by Ted Ranosa
Healthy Living/Wellness
Federal Jury Orders Gilead To Pay Merck $200 Million In Hepa C Drug Patent Dispute
by Catherine Cabral-Isabedra
Science
Gilead Pushes Through With $65 Million EpiTherapeutics Deal
by Ted Ranosa
Healthy Living/Wellness
Gilead Sciences And Zydus Launch SoviHep Hepatitis C Drug
by Sumit Passary
Science
Gilead Sciences Purchases the Next Potential 'Blockbuster Drug'
by Dianne Depra
Healthy Living/Wellness
Gilead Sciences and CVS Partner for Hepatitis C Drug
by Sumit Passary
Healthy Living/Wellness
Expensive hepatitis C drug Sovaldi to be made cheaper in developing countries
by Sumit Passary
Healthy Living/Wellness
Hepatitis C drug Sovaldi gets NICE approval despite being pricey
by Lori Sandoval

Gilead Sciences

COVID-19 Cure Update: U.S. FDA OKs Issuing Emergency Authorization to Use Injected Drug Remdesivir as Cure to Patients with Coronavirus

[BREAKING] COVID-19 Cure: Gilead Shares Remdesivir's Success in 'Crucial Study'

Pharma Giant Gilead Allegedly Tries to Monopolize the Coronavirus Cure; Retracts the Orphan Drug Status

Gilead To Donate HIV Prevention Pill Truvada To 200,000 People

Federal Jury Orders Gilead To Pay Merck $200 Million In Hepa C Drug Patent Dispute

Gilead Pushes Through With $65 Million EpiTherapeutics Deal

Gilead Sciences And Zydus Launch SoviHep Hepatitis C Drug

Gilead Sciences Purchases the Next Potential 'Blockbuster Drug'

Gilead Sciences and CVS Partner for Hepatitis C Drug

Expensive hepatitis C drug Sovaldi to be made cheaper in developing countries

Hepatitis C drug Sovaldi gets NICE approval despite being pricey

Snapdragon 8 Elite Is Qualcomm's Answer to Apple's A18 Pro, Apple Intelligence, But Can It Rise Above?

Top 10 Most Anticipated 'Pokemon Legends Z-A' Mega Evolutions That Redditors Want to See

Nintendo Music App, a.k.A. 'Nintendo Spotify,' Launch New Streaming Platform Featuring Game OSTs

'Cyberpunk 2077' Is Coming to Apple's Macs but Exclusive to M-Series Silicon Chips

Pixel 9-Exclusive Weather App to Roll Out to Older Models Soon